Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease dementia
Phenotype C0752347|lewy body disease
Sentences 12
PubMedID- 23648146 It is important that combinations of neuroimaging markers in irbd are considered for the purpose of diagnosing neurodegenerative diseases such as parkinson disease (pd), dementia with lewy body disease (dlb), or multiple system atrophy (msa) at an early stage.
PubMedID- 20522091 Pathologic correlates of dementia in individuals with lewy body disease.
PubMedID- 22174510 F18-fdg pet images of dementia with lewy body disease.
PubMedID- 22355530 In addition to being implicated in pd, as also plays a key role in other neurodegenerative disorders, such as dementia associated with lewy body disease, diffuse lewy body disease and multiple system atrophy4.
PubMedID- 21387694 Additionally, we studied dementia with lewy body disease (dlb).
PubMedID- 21734300 Abnormally accumulated alpha-synuclein (alpha-syn) is a pathological hallmark of lewy body-related disorders such as parkinson's disease (pd) and dementia with lewy body disease (dlb).
PubMedID- 21232086 Β-amyloid peptide (aβ) has been reported to exist in numerous diseases such as alzheimer's disease (ad), parkinson's disease (pd), age-related macular degeneration and lewy body disease with dementia [1-3].
PubMedID- 25766757 Several longitudinal studies have revealed that a high proportion of irbd patients convert to alpha-synucleinopathies such as parkinson's disease and dementia with lewy body disease (dlb).
PubMedID- 20132485 Intracytoplasmic alpha-synuclein (alpha-syn) amyloidogenic inclusions are a major pathological feature of parkinson's disease, dementia with lewy body disease and multiple systems atrophy.
PubMedID- 26055864 Rbd etiologies include parkinson disease, multisystem atrophy, and dementia with lewy body disease.
PubMedID- 26203309 This group includes parkinson’s disease, dementia with lewy body disease, and multiple system atrophy [18].
PubMedID- 23487816 There were also no features of infection, prion disease, acute or chronic wernicke's encephalopathy, subacute combined degeneration or chronic neurodegenerative disease including frontotemporal lobar degeneration, alzheimer's disease or dementia with lewy body disease.

Page: 1